Sulzer IntraTherapeutics To Submit PMA For Renal Indication In Early 2002
This article was originally published in The Gray Sheet
Executive Summary
Sulzer Medica's IntraTherapeutics unit intends to submit a premarket approval application to FDA for use of its IntraStent DoubleStrut ParaMount XS stent delivery system in the renal artery in the first quarter of 2002.